Month: April 2012

SEMERGEN and ESTEVE create a chronicity Chair together with the Catholic University of Valencia -One of the essential objectives of the Chair next to the educational and training activities is the promote research integrated pathology Chronicles. -heart failure and chronic kidney disease are, initially, the main axes on which rotate the teaching and research work. Valencia, April 2012.- The Spanish society of physicians in primary care (SEMERGEN), in collaboration with ESTEVE, has signed the agreement for the creation of the SEMERGEN-ESTEVE Chair of chronicity, along with the Catholic University of Valencia San Vicente Mártir (UCV). According to José Luis Llisterri, Chairman of SEMERGEN and director of the Chair the signing of this agreement means an important approach to the University, that will boost the research from the perspective of family medicine in the Faculty of medicine ”. The Act has been chaired by the Minister of health, Luis Rosado, and José Alfredo Peris, Rector of the UCV. SEMERGEN President has stressed that this new Chair is born with the intention of being a national point of reference on the knowledge of chronic diseases and in the generation of scientific evidence in this area ”. This Chair, concocted during more than one year of work, is intended to encourage research, study and realization of scientific and clinical work in the area of the chronic patient care. José Luis Llisterri said...

the medical interest in genetic for correct nutrition studies -The progress made in the exact microarrays directed, developed by Genotest, get a study of genetic polymorphisms altered in an accurate, fast and economic way -the unit of Endocrinology of the Euroclínica group, has been developing the application of the alteration in genetic polymorphisms, by NutriCheck, designed by the Genotest laboratory -the usefulness of this is to assess the degree of the predisposition to suffer from some of these pathologies: obesity, diabetes mellitus type II and hiperlipemias Madrid, April 2012.- genetic studies that serve support the medical clinician for the assessment and treatment of some metabolic pathologiesbegins to bear fruit. Advances made by one of the laboratories specialized in genetics, as the exact microarrays directed developed by Genotest, a study of genetic polymorphisms altered in an accurate, fast and economic way. The unit of Endocrinology of the Group Euroclínica, one of the pioneers in the diagnosis of obesity, diabetes, and responsible for the most frequent cardiovascular pathology hiperlipemias, begins to results after the study of alterations in the genetic polymorphisms, using the NutriCheck, the genetic test of Genotest (www.genotest.es). The usefulness of the NutriCheck is based on evaluating the degree of predisposition to suffer from some of these pathologies: obesity, diabetes mellitus type 2 and hiperlipemias. In addition, the lines of action on the food standard specifies the specialist to...